WHO pharmaceuticals newsletter - No. 2, 2022

Overview

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and legal actions taken by regulatory authorities around the world. It also provides signals based on information from the WHO global database of individual case safety reports, VigiBase.
In addition, this edition includes summaries of discussions and key recommendations of Advisory
Committee on Safety of Medicinal Products (ACSoMP) Eighteenth meeting and Global Advisory Committee on Vaccine Safety (GACVS) meetings held in 2021.